{"transactions":[{"id":2003095,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":116663,"kind":"person","name":"NASSHORN PATRICIA","position":1,"cik":"0001251374","reported_name":"NASSHORN PATRICIA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-21T17:03:07.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":97900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option becomes exercisable in eight equal semi-annual installments beginning on August 16, 2023."}],"balance_after":97900,"derivative":{"exercise_price":3.21,"expiration_date":"2033-02-15","underlying":"Common Stock","underlying_shares":97900},"source":{"system":"sec-edgar","filing":"0001209191-23-011270","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251374/000120919123011270/doc4.xml","form_type":"4"}},{"id":2315091,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":116663,"kind":"person","name":"NASSHORN PATRICIA","position":1,"cik":"0001251374","reported_name":"NASSHORN PATRICIA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-29T17:22:25.000Z","date":"2022-03-25","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 25, 2022."}],"balance_after":10000,"derivative":{"exercise_price":5.01,"expiration_date":"2032-03-24","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-22-021502","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251374/000120919122021502/doc4.xml","form_type":"4"}},{"id":2447980,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":116663,"kind":"person","name":"NASSHORN PATRICIA","position":1,"cik":"0001251374","reported_name":"NASSHORN PATRICIA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-04T17:00:53.000Z","date":"2021-12-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in four equal semi-annual installments beginning on June 15, 2022."}],"balance_after":100000,"derivative":{"exercise_price":11.24,"expiration_date":"2031-12-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-22-000537","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1251374/000089924322000537/doc4.xml","form_type":"4"}}]}